1. Home
  2. TRIB vs AXDX Comparison

TRIB vs AXDX Comparison

Compare TRIB & AXDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRIB
  • AXDX
  • Stock Information
  • Founded
  • TRIB 1992
  • AXDX 1982
  • Country
  • TRIB Ireland
  • AXDX United States
  • Employees
  • TRIB N/A
  • AXDX 107
  • Industry
  • TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • AXDX Biotechnology: Laboratory Analytical Instruments
  • Sector
  • TRIB Health Care
  • AXDX Industrials
  • Exchange
  • TRIB Nasdaq
  • AXDX Nasdaq
  • Market Cap
  • TRIB 25.5M
  • AXDX 13.7M
  • IPO Year
  • TRIB N/A
  • AXDX 1996
  • Fundamental
  • Price
  • TRIB $0.53
  • AXDX $0.55
  • Analyst Decision
  • TRIB
  • AXDX
  • Analyst Count
  • TRIB 0
  • AXDX 0
  • Target Price
  • TRIB N/A
  • AXDX N/A
  • AVG Volume (30 Days)
  • TRIB 40.2K
  • AXDX 75.6K
  • Earning Date
  • TRIB 05-22-2025
  • AXDX 05-07-2025
  • Dividend Yield
  • TRIB N/A
  • AXDX N/A
  • EPS Growth
  • TRIB N/A
  • AXDX N/A
  • EPS
  • TRIB N/A
  • AXDX N/A
  • Revenue
  • TRIB $59,126,000.00
  • AXDX $11,698,000.00
  • Revenue This Year
  • TRIB $11.63
  • AXDX $7.25
  • Revenue Next Year
  • TRIB $10.13
  • AXDX N/A
  • P/E Ratio
  • TRIB N/A
  • AXDX N/A
  • Revenue Growth
  • TRIB N/A
  • AXDX N/A
  • 52 Week Low
  • TRIB $0.48
  • AXDX $0.49
  • 52 Week High
  • TRIB $3.55
  • AXDX $2.09
  • Technical
  • Relative Strength Index (RSI)
  • TRIB 37.41
  • AXDX 21.72
  • Support Level
  • TRIB $0.51
  • AXDX $0.50
  • Resistance Level
  • TRIB $0.60
  • AXDX $0.64
  • Average True Range (ATR)
  • TRIB 0.05
  • AXDX 0.07
  • MACD
  • TRIB 0.00
  • AXDX -0.00
  • Stochastic Oscillator
  • TRIB 35.35
  • AXDX 21.07

About TRIB Trinity Biotech plc

Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.

About AXDX Accelerate Diagnostics Inc.

Accelerate Diagnostics Inc is an in vitro diagnostics company dedicated to providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. Its Clinical Microbiology products include Accelerate Pheno system, Accelerate PhenoTest BC Kit, and Accelerate Arc module & BC kit. The company earns the majority of its revenue from the domestic market. The group operates as one operating segment, deriving instrument, consumable, and service revenues from customers engaged in healthcare diagnostics within the United States. Product revenue is derived from the sale or rental of instruments and sales of related consumable products. Service revenue is derived from the sale of extended service agreements.

Share on Social Networks: